16 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MEDNEXT SURGICAL BUR
FDA 510(k)
FDA Class 1
·General, Plastic Surgery
artegral
FDA UDI
Merz Dental GmbH·D7091970023·anteriors; shade A1; mould UBL
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690119753·TIBIAL BASEPLATE/INSERT IMPACTOR
N.A.
FDA UDI
Forestadent Bernhard Förster GmbH·EFOR89700231·Mand. 2. Molar band W-Fit right 23
Paltop
FDA UDI
PALTOP ADVANCED DENTAL SOLUTIONS LTD·07290108697421·PAI Dental Implant Ø6mm L8mm
N.A.
FDA UDI
Forestadent Bernhard Förster GmbH·EFOR89700230051·Mand. 2. Molar band W-Fit right 23
N.A.
FDA UDI
Forestadent Bernhard Förster GmbH·EFOR89700230101·Mand. 2. Molar band W-Fit right 23
N.A.
FDA UDI
Forestadent Bernhard Förster GmbH·EFOR89700230501·Mand. 2. Molar band W-Fit right 23
SPiN Thoracic Navigation System
FDA 510(k)
FDA Class 2
·Radiology
MICROSURGEON MICROWAVE TISSUE ABLATION DEVICE, MODEL MTAD-100
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
ZMR®
FDA UDI
Zimmer, Inc.·00889024158900·
ZMR®
FDA UDI
Zimmer, Inc.·00889024158894·
OMNIPOD INSULIN PUMP
FDA Adverse Event
Malfunction
·INSULET CORPORATION·Product code LZG·April 28, 2014
POWERED WHEELCHAIR
FDA Adverse Event
Malfunction
·INVACARE TAYLOR STREET·Product code ITI·February 20, 2013
TERUMO CDI 500 BLOOD PARAMETER MONITOR
FDA Adverse Event
Malfunction
·TERUMO CARDIOVASCULAR SYSTEMS CORP.·Product code DRY·January 14, 2011
Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017